[
  {
    "ts": null,
    "headline": "Elevance Looks Cheap Now: But is it Time to Buy or Dodge?",
    "summary": "Strong capital efficiency and commercial growth make ELV appealing, but regulatory and cost headwinds keep investors cautious.",
    "url": "https://finnhub.io/api/news?id=aef2f7c22589bbbe0db705d1ded885c03f750db521eb0e8da5a7d239c7f65b44",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748437860,
      "headline": "Elevance Looks Cheap Now: But is it Time to Buy or Dodge?",
      "id": 134755817,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ELV",
      "source": "Yahoo",
      "summary": "Strong capital efficiency and commercial growth make ELV appealing, but regulatory and cost headwinds keep investors cautious.",
      "url": "https://finnhub.io/api/news?id=aef2f7c22589bbbe0db705d1ded885c03f750db521eb0e8da5a7d239c7f65b44"
    }
  },
  {
    "ts": null,
    "headline": "Elevance Health, Inc. (ELV) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit",
    "summary": "BENSALEM, Pa., May 28, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit...",
    "url": "https://finnhub.io/api/news?id=788beee112c84f0c33863bffa0790a239fdab7cb098f1aea56ad8b48c92846c7",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748433671,
      "headline": "Elevance Health, Inc. (ELV) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit",
      "id": 134743835,
      "image": "",
      "related": "ELV",
      "source": "Finnhub",
      "summary": "BENSALEM, Pa., May 28, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit...",
      "url": "https://finnhub.io/api/news?id=788beee112c84f0c33863bffa0790a239fdab7cb098f1aea56ad8b48c92846c7"
    }
  },
  {
    "ts": null,
    "headline": "Elevance Health Reaffirms 2025 Earnings Guidance Of $28.30-$29.00 Per Share - SEC Filing",
    "summary": "Elevance Health Inc: * REAFFIRMS 2025 EARNINGS GUIDANCE OF $28.30-$29.00 PERSHARE -SEC FILING * CONTINUES TO EXPECT 2025 ADJUSTED EARNINGS TO BE$34.15-$34.85PER SHARE -...",
    "url": "https://finnhub.io/api/news?id=3c2dd2b8ad2b715fc82f7db79e14ebddfca45f39b84da92a84c55082849eed2e",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748418446,
      "headline": "Elevance Health Reaffirms 2025 Earnings Guidance Of $28.30-$29.00 Per Share - SEC Filing",
      "id": 134740541,
      "image": "",
      "related": "ELV",
      "source": "Finnhub",
      "summary": "Elevance Health Inc: * REAFFIRMS 2025 EARNINGS GUIDANCE OF $28.30-$29.00 PERSHARE -SEC FILING * CONTINUES TO EXPECT 2025 ADJUSTED EARNINGS TO BE$34.15-$34.85PER SHARE -...",
      "url": "https://finnhub.io/api/news?id=3c2dd2b8ad2b715fc82f7db79e14ebddfca45f39b84da92a84c55082849eed2e"
    }
  }
]